International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10807529
Original Article
A Study on Correlation of Magnetic Resonance Imaging (MRI) with Histopathological Findings in Evaluating Sellar Region Tumors
 ,
Published
Feb. 29, 2024
Abstract

Aims and objectives: To determine the diagnostic accuracy of Magnetic Resonance Imaging (MRI) in the detection of sellar region tumors and to study the correlation between MRI and histopatological findings in their evaluation.

Materials and methods: An analytical cross-sectional study was performed in the department of Radiology and imaging in collaboration with department of Neurosurgery and Pathology, ASRAM Medical college and Hospital, Eluru, during the period of May 2022 to March 2023. MRI of brain was performed using 1.5 Tesla MRI scanner, Seimens Magnetom Avento Syngo (MR D- 13) 16 channel machine on 35 patients referred for evaluation of sellar region tumors and the findings were correlated with histopathological results post-operatively.

Results: The mean age group of sellar region tumors was 32.4 (±1.85) years. Most common sellar region lesion diagnosed on MRI was pituitary macroadenoma comprising 37% of the total cases. Among the total MRI diagnosed 35 cases, 28 (80%) cases were confirmed histopathologically. The accuracy, sensitivity, specificity, and negative predictive value (NPV) of MRI in diagnosing sellar region tumors were in the range of 88.9- 94.3%, 80- 91.7%, 89.7-96.7%, and 95.5- 96.7%, respectively.

Conclusion: The sensitivity and specificity of MRI in diagnosing various types of sellar region tumors almost paralleled histopathological results (gold standard) and was found in between 82% to 91%. This research concludes that MRI is a useful imaging technique for the diagnosis of malignancies in the sellarregions and pituitary adenoma

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
1123 Views
293 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved